• SP600125: Advanced JNK Inhibitor Workflows for Inflammation

  2026-06-30

  SP600125 from APExBIO is a highly selective JNK inhibitor enabling precise dissection of apoptosis, cytokine modulation, and inflammation pathways. This guide delivers actionable protocols, troubleshooting insights, and domain-bridging strategies for maximizing experimental reproducibility in both in vitro and in vivo models.

• NBC19: A Precision NLRP3 Inflammasome Inhibitor for Inflamma

  2026-06-30

  NBC19 sets a new benchmark as a nanomolar NLRP3 inflammasome inhibitor, enabling highly reproducible investigation of inflammation pathways in cellular models. Its robust modulation of IL-1β release and compatibility with Nigericin- and ATP-induced workflows make it indispensable for dissecting immune responses and optimizing sepsis-related assays.

• Translating AMPK Activation: AICAR as a Strategic Lever in M

  2026-06-29

  This thought-leadership article explores how AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) enables translational researchers to dissect and manipulate energy metabolism, inflammation, and cellular stress pathways. Integrating mechanistic insights, cross-study evidence, and workflow guidance, it provides a strategic framework for deploying AICAR in advanced metabolic disease and fibrosis models, with a focus on maximizing translational impact.

• Proteoform-Specific Drug Targeting Revealed by Native MS

  2026-06-29

  This study pioneers native top-down mass spectrometry to define proteoform-specific interactions between drugs and membrane proteins within their native lipid bilayers. The findings highlight how post-translational modifications and alternative splicing influence drug binding, with direct implications for the rational design of safer, more selective therapeutics—including PDE5 inhibitors such as Vardenafil.

• Deep Learning Reveals Cardiotoxicity in iPSC-CM Screening

  2026-06-28

  Grafton et al. pioneered a high-throughput platform using deep learning and human iPSC-derived cardiomyocytes to sensitively detect drug-induced cardiotoxicity. This approach advances early-stage drug safety assessment and informs translational research in autophagy, apoptosis, and membrane transporter signaling.

• Wortmannin as a Precision Tool: PI3K Inhibition in Apoptosis

  2026-06-27

  Explore how Wortmannin, a potent PI3K inhibitor, enables advanced apoptosis assays and pathway dissection beyond standard cancer research. This article uniquely bridges insights from viral immune evasion to experimental design, offering depth not found in current resources.

• Standardized Whole-Blood Stimulation Reveals Immunometabolic

  2026-06-26

  This protocol paper introduces a standardized workflow to assess immune responses under metabolic modulation using whole-blood stimulation. Its key innovation is the integration of metabolic inhibitors, such as 2-Deoxy-D-glucose, to dissect how specific metabolic pathways regulate cytokine production, providing a robust platform for immunometabolic research.

• Fluo-4 AM: Optimizing Intracellular Calcium Imaging Workflow

  2026-06-26

  Fluo-4 AM sets a new benchmark for high-sensitivity intracellular calcium measurement, offering rapid cell loading and robust signal for real-time functional assays. This article connects advanced protocol optimization with practical troubleshooting, leveraging comparative insights from cutting-edge artificial photoreceptor research and scenario-driven calcium imaging studies.

• 6-FAM SE: Precision Fluorescent Labeling in Molecular Biolog

  2026-06-25

  6-FAM SE (6-Carboxyfluorescein N-hydroxysuccinimide ester) redefines durable, high-sensitivity labeling for DNA, proteins, and peptides—empowering workflows from gene sequencing to advanced nanoparticle assays. Its superior hydrolytic stability and amine-reactive chemistry make it a trusted choice for researchers demanding robust fluorescent detection in challenging experimental contexts.

• Sulfo-NHS-SS-Biotin: Cleavable Biotinylation for Protein Pur

  2026-06-25

  Sulfo-NHS-SS-Biotin is a water-soluble, cleavable biotin disulfide N-hydroxysulfosuccinimide ester used for selective, reversible protein labeling. Its unique disulfide spacer enables purification and downstream analysis of cell surface proteins with high specificity. The reagent's aqueous solubility and membrane impermeance make it a preferred choice for affinity workflows targeting primary amines.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-06-24

  Anlotinib hydrochloride enables precise inhibition of angiogenesis and tumor cell proliferation through multi-target tyrosine kinase blockade, outperforming legacy inhibitors in both potency and selectivity. This guide delivers actionable protocols and troubleshooting for advanced cancer research workflows, leveraging unique mechanistic insights for reproducible, high-impact results.

• Acridine Orange hydrochloride: Protocols for DNA/RNA Stainin

  2026-06-23

  Acridine Orange hydrochloride enables differential staining of DNA and RNA in cytochemical workflows, supporting cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid staining. It is not suitable for long-term solution storage or non-nucleic acid-specific applications, and users should adhere closely to product-based specifications for consistent results.

• Binding Constants of β2-Adrenergic Receptor with Key Drugs v

  2026-06-23

  This study introduces a novel open-tubular capillary electrochromatography (CEC) approach to determine binding constants between β2-adrenergic receptors (β2-AR) and seven drugs, including norepinephrine bitartrate. By employing a part-coated capillary design, the method enables accurate, efficient affinity measurements while minimizing receptor consumption, offering significant advantages for drug-receptor interaction studies and natural product screening.

• Pravastatin Sodium: Optimizing HMG-CoA Reductase Inhibition

  2026-06-22

  Pravastatin sodium delivers highly selective, reproducible HMG-CoA reductase inhibition in both cellular and animal models, making it an essential tool for cholesterol biosynthesis research. This guide details advanced workflows, troubleshooting, and key innovations for maximizing assay performance and data reliability using APExBIO’s validated compound.

• M344: Epigenetic Precision in Cancer and HIV Latency Researc

  2026-06-22

  Explore the unique role of M344 as a potent histone deacetylase inhibitor in advanced cancer and HIV latency research. This in-depth analysis highlights M344’s mechanistic impact, protocol nuances, and critical comparative insights for experimental design.

438 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page